Thomson Medical Group A50 has received a further extension of three months to restore its public float.
The company made an appeal to Singapore Exchange S68 Securities Trading (SGX-ST) on Jan 12 after receiving a rejection for its application for a further extension of time to restore its public float two days prior.
In its appeal, the company said that in conjunction with the restoration of its public float, it intends to undertake roadshows after the Lunar New Year festive period in February. The roadshows will take into account the company’s financial results for the six months ended Dec 31 which will be announced by mid-February 2024 and its recent acquisition of the FV hospital in Vietnam.
Upon re-consideration of its decision, SGX-ST has granted Thomson Medical until April 10 to explore options to restore its public float.
Shares in Thomson Medical closed 0.1 cents lower or 1.85% down at 5.3 cents on Jan 17.
